|
|
Diagnostic markers for ME-CFIDS-CFS |
There
are a good number of scientific markers of abnormalities in this disease.
Here are just some of those: |
||
1 |
Spectroscopic diagnosis of Chronic Fatigue Syndrome by visible and near-infrared spectroscopy in serum samples. Japanese researchers concluded that “Vis-NIR spectroscopy for sera combined with chemometrics analysis could provide a promising tool to objectively diagnose CFS.” |
Fatigue Clinical Center in Osaka, Japan | |
2 |
Abnormal brain SPECT & PET scans |
The Clinical and Scientific Basis of Myalgic Encephalomyelitis/CFS Dr. Byron Hyde |
|
3 |
Mitochondrial encephalopathy |
Dr. Paul Cheney using Magnetic Resonance Spectroscopy |
|
4 |
Abnormal capillary flow due to high percentage of flat red blood cells instead of the normal discoid shaped red blood cells | Dr. Les Simpson, rheologist from New Zealand | |
6 |
Reduced red blood cell mass (RBC) |
...is a critical hematological marker of ME-CIFDS-CFS. (University of Miami) |
|
7 |
Low circulating blood volume | Dr. David Bell, Lyndonville, New York | |
8 |
Abnormal bicycle ergometry test with gas analysis indicating immediate movement to anaerobic threshold in ME-CFIDS patients | Dr.
Paul Cheney, who used this test for his disability reports |
|
9 |
High percentage of patients with a viral load (HHV-6, EBV, cytomegalovirus) and/or Mycoplasma bacteria | Dr. Ablashi, Dr. Knox, Dr. Carrigan, Dr. Nicholson | |
10 |
Cardiac abnormalities due to viral invasion into the heart | Dr. Martin Lerner | |
11 |
Disregulated HPA axis | Dr. Mark Demitrack, Dr. Anthony Komaroff | |
12 |
Disregulated antiviral pathway | Dr. Suhadolnik | |
13 |
RNase L enzyme test | Dr. Robert Suhadolnik | |
14 |
Head-up tilt test with haemodynamic instability | Dr. J. E. Naschitz | |
15 |
Abnormal T-helper 1/T-helper 2 Function Panel | Dr. Paul Cheney | |
16 |
Very low/impaired Natural Killer Cell Function | Dr. Paul Cheney, Dr. Kenny Demeirleir | |
17 |
Prolonged vasodilatory effect of acetylcholine on the microvasculature |
...in addition to Peripheral Cholinergic illness in ME-CFIDS patients,
Gulf War Illness, and illness following Organophosphate Exposure. (Dr. Vance Spence) |
|
18 |
Cardiomyopathy, liver failure, pancreatic cancer, brain tumors & renal disease |
...reported after 40 years of research in Enteroviral and Toxin Mediated
ME-CFIDS and Other Organ Pathologies. (Dr. John Richardson) |
|
19 |
Positive testing for Ciguatera Toxin Epitope |
Dr. Yoshitsugi Hokama (Research funded by the National CFIDS/M.E. Foundation) |
|
20 |
Neurally mediated hypotension | ||
21 |
Abnormal “voyager” RNA (Preliminary studie) | Dr. Paul Cheney | |
22 |
5-HIAA, a metabolite of serotonin, may be present in elevated levels in ME-CFIDS patients | Georgetown University | |
23 |
Concentrations of a glucose metabolite in red blood cells | ||
24 |
Differences in gene expression profiles | Dr. William Reeves in the cfids Chronicle | |
25 |
Excess nitric oxide activity | ||
26 |
Blood hypercoagulability | ||
27 |
Subclinical adrenal insufficiency | (present in about 2/3's of cases) | |
28 |
Reduced body temperature | (can be caused by hypoadrenal +/- hypothyroid) | |
29 |
Magnesium deficiency | ||
Many thanks
so far to the following gentlemen: |
Blake Graham from Australia.
Check out his very interesting site on nutrition and fatigue/ME-CFIDS-CFS
subsite: Nutritional-healing.com.au Steven Du Pre isaiah43 (at) lanset (dot) com |